Titre : Infarctus cérébral

Infarctus cérébral : Questions médicales fréquentes

Termes MeSH sélectionnés :

Extracellular Matrix
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Infarctus cérébral : Questions médicales les plus fréquentes", "headline": "Infarctus cérébral : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Infarctus cérébral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-08", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Infarctus cérébral" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infarctus encéphalique", "url": "https://questionsmedicales.fr/mesh/D020520", "about": { "@type": "MedicalCondition", "name": "Infarctus encéphalique", "code": { "@type": "MedicalCode", "code": "D020520", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "CADASIL", "alternateName": "CADASIL", "url": "https://questionsmedicales.fr/mesh/D046589", "about": { "@type": "MedicalCondition", "name": "CADASIL", "code": { "@type": "MedicalCode", "code": "D046589", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250.200.100" } } }, { "@type": "MedicalWebPage", "name": "Infarctus du territoire de l'artère cérébrale antérieure", "alternateName": "Infarction, Anterior Cerebral Artery", "url": "https://questionsmedicales.fr/mesh/D020243", "about": { "@type": "MedicalCondition", "name": "Infarctus du territoire de l'artère cérébrale antérieure", "code": { "@type": "MedicalCode", "code": "D020243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250.200.400" } } }, { "@type": "MedicalWebPage", "name": "Infarctus du territoire de l'artère cérébrale moyenne", "alternateName": "Infarction, Middle Cerebral Artery", "url": "https://questionsmedicales.fr/mesh/D020244", "about": { "@type": "MedicalCondition", "name": "Infarctus du territoire de l'artère cérébrale moyenne", "code": { "@type": "MedicalCode", "code": "D020244", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250.200.450" } } }, { "@type": "MedicalWebPage", "name": "Infarctus du territoire de l'artère cérébrale postérieure", "alternateName": "Infarction, Posterior Cerebral Artery", "url": "https://questionsmedicales.fr/mesh/D020762", "about": { "@type": "MedicalCondition", "name": "Infarctus du territoire de l'artère cérébrale postérieure", "code": { "@type": "MedicalCode", "code": "D020762", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250.200.475" } } } ], "about": { "@type": "MedicalCondition", "name": "Infarctus cérébral", "alternateName": "Cerebral Infarction", "code": { "@type": "MedicalCode", "code": "D002544", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Alexander E Merkler", "url": "https://questionsmedicales.fr/author/Alexander%20E%20Merkler", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Weill Cornell Medical College, New York, NY, USA; Clinical and Translational Neuroscience Unit, Weill Cornell Medical College, New York, NY, USA. Electronic address: alm9097@med.cornell.edu." } }, { "@type": "Person", "name": "Hooman Kamel", "url": "https://questionsmedicales.fr/author/Hooman%20Kamel", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Weill Cornell Medical College, New York, NY, USA; Clinical and Translational Neuroscience Unit, Weill Cornell Medical College, New York, NY, USA." } }, { "@type": "Person", "name": "Jonathan W Weinsaft", "url": "https://questionsmedicales.fr/author/Jonathan%20W%20Weinsaft", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Weill Cornell Medical College, New York, NY, USA." } }, { "@type": "Person", "name": "Grégoire Boulouis", "url": "https://questionsmedicales.fr/author/Gr%C3%A9goire%20Boulouis", "affiliation": { "@type": "Organization", "name": "Department of Neuroradiology, Centre Hospitalier Saint-Anne, Paris, France." } }, { "@type": "Person", "name": "Nan Wang", "url": "https://questionsmedicales.fr/author/Nan%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Neurology Inspection, People's Hospital of Liaoning Province, Shenyang, Liaoning 110016, P.R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39101653", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/NRR.NRR-D-24-00243" } }, { "@type": "ScholarlyArticle", "name": "Neutrophil extracellular traps promote immune escape in hepatocellular carcinoma by up-regulating CD73 through Notch2.", "datePublished": "2024-07-03", "url": "https://questionsmedicales.fr/article/38969159", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.canlet.2024.217098" } }, { "@type": "ScholarlyArticle", "name": "The dominant role of extracellular polymeric substances produced by Achromobacter xylosoxidans BP1 in Cr(VI) microbial reduction.", "datePublished": "2024-07-02", "url": "https://questionsmedicales.fr/article/38964391", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.scitotenv.2024.174464" } }, { "@type": "ScholarlyArticle", "name": "Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals.", "datePublished": "2024-06-28", "url": "https://questionsmedicales.fr/article/38943196", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13195-024-01508-6" } }, { "@type": "ScholarlyArticle", "name": "Extracellular vesicles-derived ferritin from lipid-induced hepatocytes regulates activation of hepatic stellate cells.", "datePublished": "2024-06-27", "url": "https://questionsmedicales.fr/article/39027492", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2024.e33741" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Nécrose", "item": "https://questionsmedicales.fr/mesh/D009336" }, { "@type": "ListItem", "position": 5, "name": "Infarctus", "item": "https://questionsmedicales.fr/mesh/D007238" }, { "@type": "ListItem", "position": 6, "name": "Infarctus encéphalique", "item": "https://questionsmedicales.fr/mesh/D020520" }, { "@type": "ListItem", "position": 7, "name": "Infarctus cérébral", "item": "https://questionsmedicales.fr/mesh/D002544" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Infarctus cérébral - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Infarctus cérébral", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Infarctus cérébral", "description": "Comment diagnostique-t-on un infarctus cérébral ?\nQuels tests sont effectués après un AVC suspecté ?\nQuels signes indiquent un infarctus cérébral ?\nQuelle est l'importance du temps dans le diagnostic ?\nPeut-on utiliser l'électroencéphalogramme ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Infarctus cérébral", "description": "Quels sont les symptômes courants d'un infarctus cérébral ?\nComment reconnaître un AVC ?\nLes symptômes peuvent-ils varier ?\nUn AVC peut-il provoquer des pertes de mémoire ?\nLes symptômes sont-ils toujours soudains ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Infarctus cérébral", "description": "Comment prévenir un infarctus cérébral ?\nLe tabagisme augmente-t-il le risque ?\nLe diabète influence-t-il le risque d'AVC ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exercice régulier est-il bénéfique ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Infarctus cérébral", "description": "Quels traitements sont disponibles pour un infarctus cérébral ?\nQuand utiliser des thrombolytiques ?\nLa chirurgie est-elle nécessaire ?\nQuel rôle joue la réhabilitation ?\nLes traitements varient-ils selon le type d'AVC ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Infarctus cérébral", "description": "Quelles sont les complications possibles d'un infarctus cérébral ?\nUn infarctus cérébral peut-il entraîner des infections ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la réhabilitation ?\nLes complications psychologiques sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Infarctus cérébral", "description": "Quels sont les principaux facteurs de risque d'infarctus cérébral ?\nL'âge influence-t-il le risque d'AVC ?\nLe stress peut-il être un facteur de risque ?\nLes maladies cardiaques augmentent-elles le risque ?\nLe cholestérol élevé est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D002544?mesh_terms=Extracellular+Matrix&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un infarctus cérébral ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner ou une IRM cérébrale est utilisé pour visualiser les lésions." } }, { "@type": "Question", "name": "Quels tests sont effectués après un AVC suspecté ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des examens neurologiques sont réalisés pour évaluer l'état." } }, { "@type": "Question", "name": "Quels signes indiquent un infarctus cérébral ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme une faiblesse soudaine, des troubles de la parole ou de la vision." } }, { "@type": "Question", "name": "Quelle est l'importance du temps dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic rapide est crucial pour limiter les dommages cérébraux." } }, { "@type": "Question", "name": "Peut-on utiliser l'électroencéphalogramme ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG n'est pas standard pour l'infarctus, mais peut aider à évaluer l'activité cérébrale." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'un infarctus cérébral ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Faiblesse d'un côté du corps, troubles de la parole, et maux de tête soudains." } }, { "@type": "Question", "name": "Comment reconnaître un AVC ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez l'acronyme FAST : Faiblesse, Affaissement, Speech (parole), Temps." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent de la zone du cerveau touchée et de la gravité." } }, { "@type": "Question", "name": "Un AVC peut-il provoquer des pertes de mémoire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs, y compris des pertes de mémoire, peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours soudains ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, certains infarctus peuvent se manifester par des symptômes progressifs." } }, { "@type": "Question", "name": "Comment prévenir un infarctus cérébral ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une alimentation saine, faire de l'exercice et contrôler la pression artérielle." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque majeur pour les AVC." } }, { "@type": "Question", "name": "Le diabète influence-t-il le risque d'AVC ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète mal contrôlé augmente le risque d'infarctus cérébral." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'AVC augmentent le risque personnel." } }, { "@type": "Question", "name": "L'exercice régulier est-il bénéfique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier aide à réduire le risque d'infarctus cérébral." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour un infarctus cérébral ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anticoagulants et la réhabilitation." } }, { "@type": "Question", "name": "Quand utiliser des thrombolytiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont administrés dans les premières heures après l'apparition des symptômes." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour retirer un caillot." } }, { "@type": "Question", "name": "Quel rôle joue la réhabilitation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à récupérer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type d'AVC ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements diffèrent entre les AVC ischémiques et hémorragiques." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'un infarctus cérébral ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles de la parole, des paralysies et des problèmes cognitifs." } }, { "@type": "Question", "name": "Un infarctus cérébral peut-il entraîner des infections ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections comme la pneumonie peuvent survenir après un AVC." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la réhabilitation ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent ralentir le processus de réhabilitation et nécessiter des soins supplémentaires." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme la dépression peuvent survenir après un infarctus cérébral." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infarctus cérébral ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'AVC ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'infarctus cérébral augmente avec l'âge." } }, { "@type": "Question", "name": "Le stress peut-il être un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'augmentation du risque d'AVC." } }, { "@type": "Question", "name": "Les maladies cardiaques augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies cardiaques sont un facteur de risque important pour les AVC." } }, { "@type": "Question", "name": "Le cholestérol élevé est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé peut augmenter le risque d'infarctus cérébral." } } ] } ] }

Sources (10000 au total)

Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer's disease patients and cognitively normal individuals.

Amyloid-β (Aβ) and tau are brain hallmarks of Alzheimer's disease (AD), also present in blood as soluble biomarkers or encapsulated in extracellular vesicles (EVs). Our goal was to assess how soluble ... Single-molecule enzyme-linked assays were used to quantify Aβ42/40 and tau in plasma samples and neurally-derived EVs (NDEVs) from a cohort of APOE ε4- (n = 168) and APOE ε4+ (n = 68) cognitively norm... The soluble plasma Aβ42/40 ratio is decreased in AD patients compared to cognitively normal individuals. The amount and content (Aβ40, Aβ42, tau) of plasma NDEVs were similar between groups. Plasma ND... Soluble plasma Aβ42/40 ratio is the most robust biomarker to discriminate between AD patients and CN individuals, as it normalizes for the number of NDEVs. Analysis of NDEVs and their content pointed ...

Extracellular vesicles-derived ferritin from lipid-induced hepatocytes regulates activation of hepatic stellate cells.

EVs ferritin was detected in hepatocytes stimulated with free fatty acids (FFA) as well as in NAFLD mice. Deferoxamine (DFO) was employed to reduce ferritin levels, while GW4869 was utilized to inhibi... FFA treatment induces the formation and secretion of EVs and facilitates the release of ferritin from hepatocytes via EVs. Subsequently, EVs ferritin is hijacked by HSCs, prompting accelerated HSCs ac... This study unveils a previously underestimated role of ferritin in HSCs upon its release from hepatocytes, emphasizing DFO as a promising compound to impede NAFLD advancement....

Extracellular vesicles from II trimester human amniotic fluid as paracrine conveyors counteracting oxidative stress.

We previously demonstrated that the human amniotic fluid (hAF) from II trimester of gestation is a feasible source of stromal progenitors (human amniotic fluid stem cells, hAFSC), with significant par... II trimester hAF samples were obtained as leftover material from prenatal diagnostic amniocentesis following written informed consent. EVs were separated by size exclusion chromatography and concentra... Our protocol resulted in a yield of 6.31 ± 0.98 × 10... Our results suggest that leftover samples of II trimester human amniotic fluid can represent a feasible source of EVs to counteract oxidative damage on target cells, thus offering a novel candidate th...